Immunohistochemical detection assay for carcinoma proliferative status
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 8, 1998
Issued Date -
N/A
app pub date -
Jan 6, 1997
filing date -
Dec 5, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method of determining the proliferative status of a carcinoma is disclosed. One obtains a patient sample and then quantitatively analyzes the sample for NGAL gene expression product. The amount of NGAL expression product is compared with a standard curve to determine the S-phase value. The sample can be breast tissue or breast fluid aspirate. Alternatively, blood can by analyzed for this marker to diagnose metastasis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully